July 28 (Reuters) - ALS Ltd (ALQ) :
- ALS ACQUIRES STAKE IN EUROPEAN PHARMACEUTICAL BUSINESS
- ACQUISITION OF 49% STAKE IN EUROPEAN PHARMACEUTICAL BUSINESS
- WILL INITIALLY ACQUIRE 49% OF EQUITY IN NUVISAN FOR CONSIDERATION OF ABOUT EUR145 MILLION
- TRANSACTION IS SUBJECT TO FOREIGN CONTROL APPROVAL FROM LOCAL AUTHORITIES AND IS EXPECTED TO SETTLE WITHIN 6 WEEKS
- EXCLUSIVE 'CALL' OPTION TO BUY REMAINING EQUITY IN NUVISAN FROM JAN 1, 2024 TO SEPT 30, 2026
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$18.18 |
Change
0.130(0.72%) |
Mkt cap ! $9.220B | |||
| Open | High | Low | Value | Volume |
| $17.93 | $18.25 | $17.88 | $19.31M | 1.067M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1280 | $18.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 1280 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| ALQ (ASX) Chart |